Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial
Mathieu Seynaeve1,2, Fiona Dunbar3, Chandni Hindocha4
1Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AF, UK. Mathieu.Seynaeve@kcl.ac.uk.
CNS Drugs
|March 24, 2026
Summary
No abstract available in PubMed .


